Chromium picolinate is a familiar name on shelves abroad, usually marketed around blood sugar or metabolism. Brands ask for a Japan-made chromium product expecting the same kind of evidence base as zinc or magnesium. The actual research is weaker and more mixed than that expectation, chromium is not one of Japan’s nutrient-function minerals, and there is a real, if rare, safety signal at high doses that deserves an honest mention.
This guide covers what the trial evidence on chromium and glucose actually shows, chromium’s regulatory status in Japan, and the formulation points that follow from both.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a chromium product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A meta-analysis of randomised trials found no association between chromium supplementation and glucose or insulin concentrations in people without diabetes, with mixed and inconclusive results in people with diabetes, while separate case reports describe serious kidney injury following chromium picolinate-containing supplements at high intake.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Meta-analysis, American Journal of Clinical Nutrition 2002 (PMID 12081828) | 20 randomised controlled trials identified, 15 with adequate data analysed; 618 participants total (193 with type 2 diabetes, 425 healthy or with impaired glucose tolerance) | No association between chromium and glucose or insulin concentrations in non-diabetic subjects; one Chinese trial of 155 people with diabetes showed reduced glucose and insulin, but pooled data from 38 other diabetic participants did not support a benefit; authors called the evidence inconclusive for people with diabetes and called for better-designed trials |
| Case report, Annals of Pharmacotherapy 2006 (PMID 16492795) | Case of a 24-year-old man who developed acute renal failure and biopsy-confirmed acute tubular necrosis, requiring haemodialysis, after two weeks of a dietary supplement containing chromium picolinate alongside other stimulant-type ingredients | Causality assessment found a probable link between the supplement and the kidney injury; the case involved a combination product, not chromium picolinate alone, and the authors called for more alertness to nephrotoxic reactions from dietary supplements |
The 2002 meta-analysis is the clearer picture of ordinary supplement use: no measurable effect in people without diabetes, and unresolved, conflicting results in people with diabetes even at that point. The renal injury case is serious but rare, involved a much higher-risk combination product rather than chromium picolinate on its own, and does not establish that typical single-ingredient chromium doses carry the same risk — though it is a documented reason not to treat high-dose chromium picolinate as risk-free.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Chromium is not one of the nutrients covered by Japan’s Foods with Nutrient Function Claims (栄養機能食品) system, so a chromium product cannot carry a fixed government-approved function statement the way zinc, calcium or magnesium products can.
The Consumer Affairs Agency’s current target-nutrient list for this labelling route covers a defined set of vitamins, six minerals — zinc, potassium, calcium, iron, copper and magnesium — and n-3 fatty acids. Chromium is not on that list. A Japan-made chromium product can be sold as an ordinary food, but any function-related claim would need to go through Japan’s separate Foods with Function Claims notification route, with its own evidence requirements, rather than the fixed-wording route used for those other minerals.
Two points for a brand abroad:
- There is no shortcut fixed-wording label for chromium in Japan. Any claim beyond “contains chromium” needs its own regulatory basis.
- Japan does publish a dietary reference intake for chromium, including an adequate intake and a tolerable upper intake level for adults, even though chromium sits outside the nutrient-function labelling system. A formulation should still respect that upper limit.
💬 Need help positioning a chromium product honestly without a Japanese function claim to lean on? We prepare the regulatory comparison with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe chromium by what has actually been studied — mainly glucose and insulin response in research settings, mostly inconclusive — and never make a blood-sugar claim for the product itself.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains chromium picolinate” with the amount per serving | ”Controls blood sugar”, “supports insulin sensitivity” or any claim naming diabetes or blood glucose |
| ”Chromium has been studied in trials looking at glucose and insulin response, with mixed and largely inconclusive results” | Implying the research is settled or that a positive effect is expected |
| Recommending a dose inside Japan’s published adequate intake and upper limit range | Encouraging intake meaningfully above the adequate intake without a clear reason |
How chromium is formulated
Chromium is dosed in micrograms and most commonly supplied as chromium picolinate or another chelated form, so the specification centres on source, dose and avoiding stacking with unrelated stimulant ingredients.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or capsule, chromium picolinate | Most studied and most recognised form | Dose should stay within published safe intake ranges |
| Tablet or capsule, other chelated forms (e.g. chromium chloride, chromium nicotinate) | Alternative sourcing | Less research behind these forms specifically than picolinate |
Decisions that shape the specification:
- Amount per serving. Japan’s 2025 dietary reference intakes set an adequate intake of 10 μg/day and a tolerable upper intake level of 500 μg/day for adults; a formulation should sit comfortably within this range rather than push toward the upper limit.
- Source and purity. Chromium picolinate is the most-studied form; specify the exact chelate and its supplier documentation.
- Avoid stacking with unrelated stimulant ingredients. The renal injury case above involved a chromium picolinate product combined with other bioactive ingredients; a single-ingredient or clearly documented combination formula is easier to evaluate for safety than an undisclosed stack.
- No blood-sugar positioning. Given the weak and inconsistent glucose/insulin evidence, a chromium product should not be formulated or marketed around a blood-sugar use case.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Chromium is an established food mineral in Japan even without a nutrient-function claim available. The formulation risk sits in dose and in avoiding undisclosed combination stacking, not in chromium’s basic legal status. See the Japan-made supplement OEM page, and compare with our magnesium and zinc guides for how the nutrient-function system applies to minerals that are covered by it.
Before you ask for a quotation
A factory can quote accurately once the chromium form, the amount, and any companion ingredients are fixed.
- Chromium source (picolinate or other chelate) and amount per serving
- Confirmation the amount sits within Japan’s published adequate intake (10 μg/day) and upper limit (500 μg/day) for adults
- Dosage form
- Any companion ingredients and their amounts, disclosed in full
- Countries you will sell in, and chromium’s status and upper-limit guidance there
💬 Ready to design a Japan-made chromium product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does chromium picolinate actually help blood sugar?
A 2002 meta-analysis of 15 trials found no association between chromium supplementation and glucose or insulin in non-diabetic subjects, and mixed, inconclusive results in people with diabetes. The evidence does not support a blood-sugar claim for a general-population product.
2. Can a Japan-made chromium product carry a Japanese nutrient-function claim?
No. Chromium is not on the Consumer Affairs Agency’s current target-nutrient list for Foods with Nutrient Function Claims, which covers a defined set of vitamins, six minerals (zinc, potassium, calcium, iron, copper, magnesium) and n-3 fatty acids.
3. Is chromium picolinate dangerous?
At typical supplement doses within published safe intake ranges, no established danger is documented in the research reviewed here. A case report did describe serious kidney injury after high intake of a combination product containing chromium picolinate alongside other stimulant ingredients — a reason for caution about high doses and undisclosed stacking, not a reason to avoid chromium picolinate at documented safe levels.
4. What dose should a chromium product target?
Japan’s 2025 dietary reference intakes set an adequate intake of 10 μg/day and a tolerable upper intake level of 500 μg/day for adults. A formulation should sit within that range.
5. Should a chromium product be combined with stimulant ingredients?
The documented kidney injury case involved exactly that kind of combination. A cleaner, better-documented single-ingredient or transparently disclosed formula is easier to evaluate for safety.
Sources: “Glucose and insulin responses to dietary chromium supplements: a meta-analysis”, American Journal of Clinical Nutrition 2002;76(1) (PMID 12081828); “Acute tubular necrosis associated with chromium picolinate-containing dietary supplement”, Annals of Pharmacotherapy 2006;40(3):563-566 (PMID 16492795); Japan’s Dietary Reference Intakes (2025 edition) for the adequate intake and tolerable upper intake level of chromium in adults; Consumer Affairs Agency Foods with Nutrient Function Claims target-nutrient list for the current scope of covered vitamins, minerals and n-3 fatty acids. Checked on 25 September 2026.